SAUS:LSE:LSE-iShares MSCI Australia UCITS (GBX)

ETF | Others |

Last Closing

USD 3903

Change

-57.00 (-1.44)%

Market Cap

USD 0.40B

Volume

2.03K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

N/A

USD 292,109.19B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 592.18B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 592.18B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

N/A

USD 331.07B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
0QZO:LSE 0QZO

N/A

USD 258.54B

ETFs Containing SAUS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.92% 37% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.92% 36% F 41% F
Trailing 12 Months  
Capital Gain 12.35% 51% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.35% 50% F 57% F
Trailing 5 Years  
Capital Gain 38.06% 55% F 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 38.06% 52% F 62% D
Average Annual (5 Year Horizon)  
Capital Gain 7.43% 62% D 66% D+
Dividend Return 7.43% 61% D- 65% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.28% 55% F 70% C-
Risk Adjusted Return 55.96% 71% C- 81% B-
Market Capitalization 0.40B 66% D+ 57% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike